Genmab AS

Genmab AS Market capitalization

The The market capitalization of Genmab AS (GMAB) as of Nov 22, 2026 is 15.40 B USD. In the previous year, The market capitalization was 15.40 B USD — a change of 0.00% (lower).

Market capitalization

15.40 BUSD

YoY

0.00%

Last updated:

In 2025, Genmab AS's market cap stood at 15.40 B USD, a 0.00% increase from the 15.40 B USD market cap in the previous year.

The Genmab AS Market capitalization history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Market capitalization
Date
Market capitalization
Jan 1, 2018
15.40 B USD
Jan 1, 2019
15.40 B USD
Jan 1, 2020
15.40 B USD
Jan 1, 2021
15.40 B USD
Jan 1, 2022
15.40 B USD
Jan 1, 2023
15.40 B USD
Jan 1, 2024
15.40 B USD
Jan 1, 2025
15.40 B USD
The Genmab AS Market capitalization history
YEARMarket capitalizationYoY
15.40 BUSD0.00%
15.40 BUSD0.00%
15.40 BUSD0.00%
15.40 BUSD0.00%
15.40 BUSD0.00%
15.40 BUSD0.00%
15.40 BUSD0.00%
15.40 BUSD0.00%
15.40 BUSD0.00%
15.40 BUSD0.00%
15.40 BUSD0.00%
15.40 BUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Genmab AS Stock analysis

What does Genmab AS do? Genmab AS is a biotechnology company based in Copenhagen, Denmark, operating in the Health Care sector. It develops and markets antibody-based therapies for cancer and other diseases, including EPKINLY, TEPKINLY, and Tivdak for various lymphomas and cervical cancer. The company also advances several product candidates in clinical development, such as Epcoritamab for lymphomas and GEN1059 for solid tumors, alongside established treatments like DARZALEX and TECVAYLI for multiple myeloma and other conditions. Genmab AS is one of the most popular companies on Eulerpool.

Market capitalization Details

Exploring Genmab AS's Market Capitalization

Genmab AS's market capitalization represents the total dollar market value of the company’s outstanding shares of stock. It is calculated by multiplying the company's shares outstanding by the current market price of one share. This metric is a vital indicator of a company’s size, strength, and overall market value.

Year-to-Year Comparison

A yearly comparison of Genmab AS's market capitalization provides investors and analysts insights into its growth and valuation trends. An increase signifies market confidence and business expansion, while a decrease may point towards declining market value or business contractions.

Impact on Investments

Genmab AS's market capitalization plays a pivotal role in investment decisions. It aids investors in assessing the company's risk and return profiles. Larger companies are often considered more stable but may offer lower growth potential, while smaller companies might offer significant growth prospects but come with higher risk.

Interpreting Market Capitalization Fluctuations

Variations in Genmab AS’s market capitalization can be attributed to several factors, including changes in stock price, outstanding shares, and market sentiment. Understanding these fluctuations helps investors evaluate the company's current standing and future potential in the competitive landscape.

Frequently Asked Questions about Genmab AS stock

The market capitalization of Genmab AS is 15.40 B USD in 2025.

The market capitalization of Genmab AS changed from 15.40 B USD to 15.40 B USD, representing a 0.00% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The market capitalization Genmab AS since 2006 – with annual values, charts, and detailed analysis.

Market capitalization (German: Market capitalization, English: market capitalisation or market cap) is the calculated total value of all shares of a publicly traded company. The market capitalization of a company reflects the current market consensus on the value of the equity of a publicly traded company. It is determined by the supply and demand for the company's shares. Thus, market capitalization is significantly influenced by expectations in the stock market regarding the future earnings power of the company and, therefore, can be subject to significant fluctuations.

Number of shares * share price = market capitalization

To evaluate The market capitalization's USD, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for The market capitalization.

A 'good' USD varies by industry and company stage. On Eulerpool, you can compare The market capitalization's Genmab AS with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Genmab AS

All Key Metrics — Genmab AS